Industry News

Bleep LLC appoints Thomas P. Beckley to Board of Directors
Industry News

Bleep LLC appoints Thomas P. Beckley to Board of Directors

Bleep LLC, maker of the Eclipse™ mask-less CPAP solution, announced technologist and electronics industry veteran Tom Beckley has joined the Company’s Board of Directors. “As a successful technology entrepreneur with extensive knowledge of AI, software and advanced electro-mechanical systems, I’m very pleased Tom has joined Bleep’s Board of Directors,” said […]

Nexalin Announces Pivotal HALO Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market
Industry News Insomnia Research/Studies

Nexalin’s HALO Clarity Trial to Support Planned De Novo FDA Submission Targeting Insomnia Market

Nexalin Technology, Inc. announced continued advancement toward its planned pivotal clinical trial evaluating HALO™ Clarity for the treatment of moderate to severe insomnia, designed to support Nexalin’s planned de novo submission to the U.S. Food and Drug Administration. The study is being conducted in collaboration with Lindus Health, a full-service clinical […]

Clear Chronic Care Expands National Footprint as Medicare Infrastructure Partner for RPM, CCM and Quality Performance; Enters Sleep Medicine Market
Industry News

Clear Chronic Care Expands Nationally, Enters Sleep Medicine Market

Clear Chronic Care announced continued national expansion of its Medicare-focused Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) platform, reinforcing its position as a long-term infrastructure partner to physician practices navigating value-based reimbursement. The company also announced strategic expansion into sleep medicine, where chronic oversight and adherence management are […]

ProSomnus Secures $38 Million Investment from Catalio Capital to Scale Smart Sleep Medicine
Industry News

ProSomnus Secures $38 Million Investment from Catalio Capital to Scale Smart Sleep Medicine

ProSomnus Sleep Technologies announced a strategic investment from Catalio Capital Management, L.P. to accelerate the global expansion of its technology-enabled sleep health platform. Under the agreement, Catalio, a premier healthcare-focused investment firm, has committed up to $38 million to advance development of next-generation remote patient monitoring (RPM) and proprietary sleep […]

Alkermes Avadel Aquisition
Industry News Sleep Pharmaceuticals

Alkermes Completes Acquisition of Avadel, Accelerating Entry Into Sleep Medicine Market

Alkermes plc and Avadel Pharmaceuticals plc, announced Alkermes’ completion of its acquisition of Avadel, a commercial-stage biopharmaceutical company. The acquisition adds Avadel’s FDA-approved product, LUMRYZ®, to Alkermes’ commercial portfolio, and provides Alkermes with a commercial organization experienced in this disease state. This strategic move accelerates Alkermes’ entry into the sleep […]